Literature DB >> 26265765

Comparison of bias-corrected covariance estimators for MMRM analysis in longitudinal data with dropouts.

Masahiko Gosho1, Akihiro Hirakawa2, Hisashi Noma3, Kazushi Maruo4, Yasunori Sato5.   

Abstract

In longitudinal clinical trials, some subjects will drop out before completing the trial, so their measurements towards the end of the trial are not obtained. Mixed-effects models for repeated measures (MMRM) analysis with "unstructured" (UN) covariance structure are increasingly common as a primary analysis for group comparisons in these trials. Furthermore, model-based covariance estimators have been routinely used for testing the group difference and estimating confidence intervals of the difference in the MMRM analysis using the UN covariance. However, using the MMRM analysis with the UN covariance could lead to convergence problems for numerical optimization, especially in trials with a small-sample size. Although the so-called sandwich covariance estimator is robust to misspecification of the covariance structure, its performance deteriorates in settings with small-sample size. We investigated the performance of the sandwich covariance estimator and covariance estimators adjusted for small-sample bias proposed by Kauermann and Carroll ( J Am Stat Assoc 2001; 96: 1387-1396) and Mancl and DeRouen ( Biometrics 2001; 57: 126-134) fitting simpler covariance structures through a simulation study. In terms of the type 1 error rate and coverage probability of confidence intervals, Mancl and DeRouen's covariance estimator with compound symmetry, first-order autoregressive (AR(1)), heterogeneous AR(1), and antedependence structures performed better than the original sandwich estimator and Kauermann and Carroll's estimator with these structures in the scenarios where the variance increased across visits. The performance based on Mancl and DeRouen's estimator with these structures was nearly equivalent to that based on the Kenward-Roger method for adjusting the standard errors and degrees of freedom with the UN structure. The model-based covariance estimator with the UN structure under unadjustment of the degrees of freedom, which is frequently used in applications, resulted in substantial inflation of the type 1 error rate. We recommend the use of Mancl and DeRouen's estimator in MMRM analysis if the number of subjects completing is ( n + 5) or less, where n is the number of planned visits. Otherwise, the use of Kenward and Roger's method with UN structure should be the best way.

Keywords:  Covariance structure; missingness; mixed-effects model; robust covariance estimator; small sample

Mesh:

Year:  2015        PMID: 26265765     DOI: 10.1177/0962280215597938

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  4 in total

1.  What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression.

Authors:  Vikram Suresh; Jeffrey A Mills; Paul E Croarkin; Jeffrey R Strawn
Journal:  Depress Anxiety       Date:  2020-06-24       Impact factor: 6.505

2.  Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.

Authors:  Hisashi Noma; Kazushi Maruo; Masahiko Gosho; Stephen Z Levine; Yair Goldberg; Stefan Leucht; Toshi A Furukawa
Journal:  BMC Med Res Methodol       Date:  2019-02-14       Impact factor: 4.615

3.  Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols.

Authors:  Sebastian Häckl; Armin Koch; Florian Lasch
Journal:  Pharm Stat       Date:  2019-07-03       Impact factor: 1.894

4.  Dose-Response Mixed Models for Repeated Measures - a New Method for Assessment of Dose-Response.

Authors:  Gustaf J Wellhagen; Bengt Hamrén; Maria C Kjellsson; Magnus Åstrand
Journal:  Pharm Res       Date:  2020-07-31       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.